» Articles » PMID: 12089071

Inhibitory Effects of Novel AP-1 Decoy Oligodeoxynucleotides on Vascular Smooth Muscle Cell Proliferation in Vitro and Neointimal Formation in Vivo

Overview
Journal Circ Res
Date 2002 Jun 29
PMID 12089071
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Excessive proliferation of vascular smooth muscle cells (VSMCs) and neointimal formation are critical steps in the pathogenesis of atherosclerosis and restenosis after percutaneous transluminal angioplasty. In this study, we investigated the hypothesis that the activator protein-1 (AP-1) plays an important role in neointimal formation after vascular injury. A circular dumbbell AP-1 decoy oligodeoxynucleotide (CDODN) was developed as a novel therapeutic strategy for restenosis after angioplasty. This CDODN was more stable than the conventional phosphorothioate linear decoy ODN (PSODN) and maintained structural integrity on exposure to exonuclease III or serum. Transfection with AP-1 decoy ODNs strongly inhibited VSMC proliferation and migration, as well as glucose- and serum-induced expression of PCNA and cyclin A genes. Administration of AP-1 decoy ODNs in vivo using the hemagglutinating virus of Japan (HVJ)-liposome method virtually abolished neointimal formation after balloon injury to the rat carotid artery. Compared with PSODN, CDODN was more effective in inhibiting the proliferation of VSMCs in vitro and neointimal formation in vivo. Our results collectively indicate that AP-1 activation is crucial for the mediation of VSMC proliferation in response to vascular injury. Moreover, the use of stable CDODN specific for AP-1 activity in combination with the highly effective HVJ-liposome method provides a novel potential therapeutic strategy for the prevention of restenosis after angioplasty in humans.

Citing Articles

Transfection of Vein Grafts with Early Growth Response Factor-1 Oligodeoxynucleotide Decoy: Effects on Stem-Cell Genes and Toll-like Receptor-Mediated Inflammation.

Mylonas K, Peroulis M, Kapelouzou A Int J Mol Sci. 2023; 24(21).

PMID: 37958848 PMC: 10647335. DOI: 10.3390/ijms242115866.


NF-κB Decoy ODN-Loaded Poly(Lactic-co-glycolic Acid) Nanospheres Inhibit Alveolar Ridge Resorption.

Huang A, Ishida Y, Li K, Rintanalert D, Hatano-Sato K, Oishi S Int J Mol Sci. 2023; 24(4).

PMID: 36835111 PMC: 9962103. DOI: 10.3390/ijms24043699.


Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis.

Mahjoubin-Tehran M, Teng Y, Jalili A, Aghaee-Bakhtiari S, Markin A, Sahebkar A Int J Mol Sci. 2021; 22(9).

PMID: 33922585 PMC: 8122884. DOI: 10.3390/ijms22094420.


AAV-Mediated Expression of AP-1-Neutralizing RNA Decoy Oligonucleotides Attenuates Transplant Vasculopathy in Mouse Aortic Allografts.

Remes A, Franz M, Mohr F, Weber A, Rapti K, Jungmann A Mol Ther Methods Clin Dev. 2019; 15:246-256.

PMID: 31720303 PMC: 6838891. DOI: 10.1016/j.omtm.2019.09.009.


Molecular Pharmacological Approaches for Treating Abdominal Aortic Aneurysm.

Miyake T, Miyake T, Kurashiki T, Morishita R Ann Vasc Dis. 2019; 12(2):137-146.

PMID: 31275464 PMC: 6600097. DOI: 10.3400/avd.ra.18-00076.